VBI Vaccines Inc.

OTCPK:VBIV.Q Stock Report

Market Cap: US$14.3k

VBI Vaccines Management

Management criteria checks 3/4

VBI Vaccines' CEO is Jeff Baxter, appointed in May 2016, has a tenure of 8.5 years. total yearly compensation is $893.55K, comprised of 78.1% salary and 21.9% bonuses, including company stock and options. directly owns 0.071% of the company’s shares, worth $10.14. The average tenure of the management team and the board of directors is 7.2 years and 6.8 years respectively.

Key information

Jeff Baxter

Chief executive officer

US$893.5k

Total compensation

CEO salary percentage78.1%
CEO tenure8.5yrs
CEO ownership0.07%
Management average tenure7.2yrs
Board average tenure6.8yrs

Recent management updates

Recent updates

VBI Vaccines: Recent Updates Have Fortified My Long-Term Outlook

Sep 22

VBI Vaccines gets up to $100M debt funding from K2 HealthVentures

Sep 15

Valneva, VBI Vaccines in pact to launch Hep B vaccine in Europe

Sep 08

VBI Vaccines down 10% on $300M mixed shelf offering; also ends two equity offerings

Aug 26

VBI Vaccines: Recent VBI-1901 Data Supports My Bull Thesis

Jun 17

Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?

Jun 09
Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?

Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?

Jan 24
Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?

CEO Compensation Analysis

How has Jeff Baxter's remuneration changed compared to VBI Vaccines's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$84m

Dec 31 2023US$894kUS$698k

-US$94m

Sep 30 2023n/an/a

-US$115m

Jun 30 2023n/an/a

-US$119m

Mar 31 2023n/an/a

-US$120m

Dec 31 2022US$2mUS$678k

-US$113m

Sep 30 2022n/an/a

-US$111m

Jun 30 2022n/an/a

-US$102m

Mar 31 2022n/an/a

-US$73m

Dec 31 2021US$3mUS$605k

-US$70m

Sep 30 2021n/an/a

-US$66m

Jun 30 2021n/an/a

-US$63m

Mar 31 2021n/an/a

-US$56m

Dec 31 2020US$2mUS$535k

-US$46m

Sep 30 2020n/an/a

-US$42m

Jun 30 2020n/an/a

-US$45m

Mar 31 2020n/an/a

-US$49m

Dec 31 2019US$1mUS$500k

-US$55m

Sep 30 2019n/an/a

-US$63m

Jun 30 2019n/an/a

-US$62m

Mar 31 2019n/an/a

-US$66m

Dec 31 2018US$1mUS$465k

-US$64m

Sep 30 2018n/an/a

-US$56m

Jun 30 2018n/an/a

-US$50m

Mar 31 2018n/an/a

-US$43m

Dec 31 2017US$826kUS$450k

-US$39m

Compensation vs Market: Jeff's total compensation ($USD893.55K) is above average for companies of similar size in the US market ($USD647.72K).

Compensation vs Earnings: Jeff's compensation has been consistent with company performance over the past year.

CEO

Jeff Baxter (63 yo)

8.5yrs

Tenure

US$893,547

Compensation

Mr. Jeffery R. Baxter, also known as Jeff, FCMA, has been the Chief Executive Officer and President of VBI Vaccines Inc. since May 2016. Mr. Baxter has been the Chief Executive Officer and President of VBI...

Leadership Team

NamePositionTenureCompensationOwnership
Jeffery Baxter
President8.5yrsUS$893.55k0.071%
$ 10.1
Nell Beattie
CFO, Head of Corporate Development & Director1.6yrsno data0.0079%
$ 1.1
David Anderson
Chief Scientific Officer8.5yrsUS$564.56k0.017%
$ 2.5
Francisco Diaz-Mitoma
Chief Medical Officer8.8yrsUS$549.22k0.049%
$ 7.0
Nicole Anderson
Director of Corporate Communications & Investor Relationsno datano datano data
Athena Kartsaklis
Senior VP of Finance7.2yrsno datano data
Avi Mazaltov
Global Head of Manufacturing & GM of SciVac7.5yrsno data0.025%
$ 3.5
Misha Nossov
Senior VP of Global Commercial Supply Strategy & Head of Europe4.8yrsno datano data
T. Buckley
Senior Vice President of Business Development4.8yrsno datano data
John Dillman
Chief Commercial Officer2.3yrsno datano data

7.2yrs

Average Tenure

57.5yo

Average Age

Experienced Management: VBIV.Q's management team is seasoned and experienced (7.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jeffery Baxter
President8.5yrsUS$893.55k0.071%
$ 10.1
Nell Beattie
CFO, Head of Corporate Development & Director1.6yrsno data0.0079%
$ 1.1
Steven S. Gillis
Independent Chairperson of the Board8.5yrsUS$194.03k0.0098%
$ 1.4
Denis Burger
Member of Scientific Advisory Boardno datano datano data
Peter Patriarca
Member of Scientific Advisory Board6.8yrsno datano data
Stanley Plotkin
Member of Scientific Advisory Boardno datano datano data
Damian Braga
Chairperson of the Commercial Advisory Board & Independent Director4.7yrsUS$105.18k0%
$ 0
Michel De Wilde
Independent Director and Chair of Scientific & Clinical Advisory Board8.5yrsUS$107.68k0.0058%
$ 0.8
Blaine McKee
Independent Director5.8yrsUS$120.18k0%
$ 0
Joanne Cordeiro
Independent Director5.6yrsUS$127.68k0%
$ 0
Robert Pass
Member of Scientific Advisory Board6.8yrsno datano data
Adam Finn
Member of Scientific Advisory Board6.8yrsno datano data

6.8yrs

Average Tenure

68yo

Average Age

Experienced Board: VBIV.Q's board of directors are considered experienced (6.8 years average tenure).